Genentech Warns of Infection Risk from Alcohol Pads Packaged with Fuzeon and Pegasys

[Guest guest]

Genentech Warns of Infection Risk from Alcohol Pads Packaged with Fuzeon and

Pegasys

SUMMARY› Genentech last week notified patients that alcohol pads packaged with

certain injectable drugs -- including the HIV entry inhibitor enfuvirtide

(Fuzeon; T-20) and pegylated interferon alfa-2a (Pegasys) used to treat

hepatitis B and C -- may be contaminated with bacteria that could cause serious

infection, especially in people with suppressed immune function. Triad Group,

which manufactures the potentially contaminated alcohol pads and swabs, has

announced a market recall. Genentech emphasized that only the alcohol products,

not the medications themselves, are affected.

http://www.hivandhepatitis.com/recent/2011/0118_2011_c.html

[Guest guest]

Genentech Warns of Infection Risk from Alcohol Pads Packaged with Fuzeon and

Pegasys

SUMMARY› Genentech last week notified patients that alcohol pads packaged with

certain injectable drugs -- including the HIV entry inhibitor enfuvirtide

(Fuzeon; T-20) and pegylated interferon alfa-2a (Pegasys) used to treat

hepatitis B and C -- may be contaminated with bacteria that could cause serious

infection, especially in people with suppressed immune function. Triad Group,

which manufactures the potentially contaminated alcohol pads and swabs, has

announced a market recall. Genentech emphasized that only the alcohol products,

not the medications themselves, are affected.

http://www.hivandhepatitis.com/recent/2011/0118_2011_c.html

[Guest guest]

Genentech Warns of Infection Risk from Alcohol Pads Packaged with Fuzeon and

Pegasys

SUMMARY› Genentech last week notified patients that alcohol pads packaged with

certain injectable drugs -- including the HIV entry inhibitor enfuvirtide

(Fuzeon; T-20) and pegylated interferon alfa-2a (Pegasys) used to treat

hepatitis B and C -- may be contaminated with bacteria that could cause serious

infection, especially in people with suppressed immune function. Triad Group,

which manufactures the potentially contaminated alcohol pads and swabs, has

announced a market recall. Genentech emphasized that only the alcohol products,

not the medications themselves, are affected.

http://www.hivandhepatitis.com/recent/2011/0118_2011_c.html

[Guest guest]

Genentech Warns of Infection Risk from Alcohol Pads Packaged with Fuzeon and

Pegasys

SUMMARY› Genentech last week notified patients that alcohol pads packaged with

certain injectable drugs -- including the HIV entry inhibitor enfuvirtide

(Fuzeon; T-20) and pegylated interferon alfa-2a (Pegasys) used to treat

hepatitis B and C -- may be contaminated with bacteria that could cause serious

infection, especially in people with suppressed immune function. Triad Group,

which manufactures the potentially contaminated alcohol pads and swabs, has

announced a market recall. Genentech emphasized that only the alcohol products,

not the medications themselves, are affected.

http://www.hivandhepatitis.com/recent/2011/0118_2011_c.html